Social consequences of HIV-positive women's participation in prevention of mother-to-child transmission programmes

“Sisters, Mothers, Daughters and Aunties”: HIV Vaccine Acceptability Among African, Caribbean and Other Black Women in Toronto

“…17 Finally, the lower levels of HIV vaccine acceptability among women of African versus Caribbean descent may be a function of the particular stigma associated with HIV among people from African communities. Stigma has been identified as a barrier to uptake of a broad array of HIV prevention and treatment interventions, including condom use, 26 HIV testing, 27 prevention of mother-to-child transmission 28 and antiretroviral therapy. 29 Thus while an HIV vaccine as a universal preventive intervention may help to mitigate the stigma of AIDS, that same stigma may function as a barrier to vaccine uptake.…”

Factors Associated With Perceived Stigma Among People Living With HIV/AIDS in Post-Conflict Northern Uganda

“…Even in countries like Uganda, where the AIDS epidemic has lasted several decades, PLHIV continue to experience stigma, especially internal stigmatization, desertion, isolation, and verbal abuse (Kipp, Bajenja, Karamagi, & Tindyebwa, 2007;Medley, Kennedy, Lunyolo, & Sweat, 2009). Several studies have consistently documented that stigma impacts negatively on disclosure, delays access to health care, interferes with adherence to antiretroviral therapy and inhibits the use of prevention services for people at risk for HIV (Eide et al, 2006;Link, Struening, Rahav, Phelan, & Nuttbrock, 1997;Simbayi et al, 2007). These consequences of stigmatization enhance sexual and nonsexual transmission of HIV and impact on the quality of life of PLHIV.…”

Stigma and Discrimination against People Living with HIV in Juba, South Sudan

“…Hospitals are Juba teaching Hospital (JTH) ART Centre and Juba Military hospital (JMH) ART Centre where all the people living with HIV (PLHIV) on antiretroviral therapy (ART) both gender from 15-46 years and above converged to collect their medications [13,14]. The details of the study participants are depicted in Tables 1-5.…”